Основные результаты исследования ELSA
Abstract
About the Authors
Ю. КотовскаяRussian Federation
Ж. Кобалава
Russian Federation
References
1. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary event rates across the WHO MONICA Project populations. Lancet 2000; 355: 675-687.
2. Bond G, Wilmoth SK, Enevold GL, et al. Detection and monitoring of asymptomatic atherosclerosis in clinical trials. Am J Med 1 989; 86 (Suppl 4A): 33-36.
3. Paivansalo M, RantalaA, KaumaH, et al. Prevalence of carotid atherosclerosis in middle-aged hypertensive and control subjects. A cross-sectional systematic study with duplex ultrasound. J Hypertens 1996; 14: 1433-1439.
4. Salonen R, Salonen JT. Carotid atherosclerosis in relation to systolic and diastolic blood pressure. Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Intern Med 1991; 23: 23-27
5. Bots M.L., Hoes A.W., Koudstaal P.J. et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction. The Rotterdam Study. Circulation 1997;96:1432-1437
6. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, ef al. for the ARIC Study Group: Arterial wall thickness is associated with prevalent cardiovascular diseases in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) study. Stroke 1995; 26:386-391.
7. Furberg C.D., Adams Jr H.P., Applegate W.B. et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Curculation 1994;90:1679-1687
8. Crouse JR III, Byington RP, Bond MG et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol 1995; 75:455-459.
9. Hodis H.N, Mack W.J, Dunn M et al. Intermediate Density Lipoproteins and Progression of Carotid Arterial Wall Intima-Media Thickness. Circulation 1997;95:2022-2026.
10. Zanchetti A. Trials investigating the anti-atherosclerotic effects of antihypertensive drugs. J Hypertens 1996; 14 (suppl 2):S77-S81.
11. Lonn E. M., Yusuf S., Dzavik V. et al. Effects of Ramipril and Vitamin E on Atherosclerosis : The Study to Evaluate Carotid Ultrasound Changes in Patients Treated With Ramipril and Vitamin E (SECURE). Circulation 2001 103: 919-925
12. Pitt B., Byington R., Furberg C.D et al. for the PREVENT investiagators Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000; 102:1503
13. Hedblad, B., Wikstrand, J., Janzon, L. et al. Low Dose Metoprolol CR/XL and Fluvastatin Slow Progression of Carotid Intima-Media Thickness : Main Results From the {beta} Blocker Cholesterol Lowering Asymptomatic Plaque Study (BCAPS). Circulation 2001; 103: 1721-1726
14. Borhani N, Mercuri M, Borhani P, Buckalew V, Canossa8Terris M, Carr A, er al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA 1996; 276:785-791.
15. Zanchetti A, Agabiti Rosel E, DalPalu C, et al, for the Verapamilin Hypertension and Atherosclerosis Study (VHAS) Investigators. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima%media thickness. J Hypertens 1998; 16: 1667-1676.
16. Simon A.,Gariepy J, Moyse D, Levenson J. Differential Effects of Nifedipine and Co-Amilozide on the Progression of Early Carotid Wall Changes. Circulation 2001;103:2949
17. Paoletti R, Corsini A, Soma MR, Bernini F. Calcium, calcium antagonists and experimental atherosclerosis. Blood Pressure 1996; 5 (suppl 4): 12-15.
18. Cominacini L., Garbin U., Pasini A.F. et al. Lacidipine inhibits the activation of the transcription factor NF-kappaB and the expression of adhesion molecules induced by pro-oxidant signal on endothelial cells. Journal of Hypertension 1997;15 (12 Pt 2):1633-1640.
19. Cominacini L., Garbin U., Pasini A.F. et al. Oxidized low-density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells: inhibitory effects of lacidipine. Journal of Hypertension 1998; 16: (12Pt 2): 1913-1919
20. Cominacini L., Pasini A.F., Pastorino A.M. et al. Comparative effects of different dihydripiridines on the expression of adhesion molecules induced by TNF-alpha on endothelial cells. Journal of Hypertension 1999; 17 (12 Pt 2): 1837-1841
21. Herbette L.G. Mason PE., Gaviraghi G et al. The molecular basis for lacidipine’s unique pharmacokinetics: optimal hydrophobicity resukts in membrane interactions that may facilitate the ttreatment of atherosclerosis. Journal of Cardiovascular Pharmacol 1994; 23 (Suppl 5):S16-25
22. Mercuri M. Tang R, Phillips RM, Bond MG. Ultrasound protocol and quality control procedures in the European Lacidipine Study on Atherosclerosis (ELSA). Blood Pressure 1996; 5 (suppl 4):20-23.
23. Zanchetti A on behalf of the ELSA investigators. Prevalence of carotid atherosclerosis in hypertension: preliminary baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). Blood Pressure 1996; 5 (suppl 4):30-35.
24. Zanchetti A., Bond M.G., Henning M. et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J of Hypertension 1998;16:949-961
25. Mancia G., Parati G., Henning M. et al. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J of Hypertension 2001;19:1981-1989.
26. Tang R., Henning M., Thomasson B. et al. Baseline reproducibility of B0-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). ). J of Hypertension 2000;18:197-201.
Review
For citations:
, . Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2002;(4):23-33.
Email this article 